Internal Medicine, Gastroenterology · Saint Louis, MO
NPI
1972811974
Since 2010
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1 Barnes Jewish Hospital Plz, Div Im Gastroenterology
Saint Louis, MO, 63110
Phone (314) 747-2075
Groups this clinician bills Medicare through
Medicare paid, 2024
$23K
235 services
Medicare patients, 2024
149
Average age 68
Drug cost, 2024
$9.0M
1,072 prescriptions
Company payments, 2025
$122K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Parakkal Deepak was code 99214 (office e&m - established), 83 times for 58 patients. In total Parakkal Deepak billed 235 services in 21 codes, and Medicare paid $23K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 83 | 58 | $86.87 | $7,210 |
| 45380 Lower GI Endoscopy - Other | Facility | 33 | 33 | $113.39 | $3,742 |
| 99222 Hospital E&M - Initial | Facility | 28 | 28 | $95.85 | $2,684 |
| 43239 Upper GI Endoscopy | Facility | 15 | 15 | $77.31 | $1,160 |
| 45385 Colonoscopy - Lesion Removal | Facility | 12 | 12 | $198.61 | $2,383 |
| 99213 Office E&M - Established | Office | 12 | 11 | $58.10 | $697 |
By year: 2022 $28K for 266 services; 2023 $24K for 488 services; 2024 $23K for 235 services.
Medicare prescription drug claims, 2024
In 2024, the drug Parakkal Deepak prescribed most often to Medicare patients was Stelara (Ustekinumab), with 219 prescriptions and refills. In total Parakkal Deepak wrote 1,072 Medicare prescriptions that cost $9.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Stelara Ustekinumab | 219 | 258 | 27 | $6.1M |
| Mesalamine Generic | 76 | 120 | 16 | $29K |
| Skyrizi On-Body Risankizumab-Rzaa | 52 | 97 | 14 | $1.1M |
| Humira(Cf) Pen Adalimumab | 48 | 56 | Under 11 | $577K |
| Rinvoq Upadacitinib | 47 | 55 | Under 11 | $402K |
| Sulfasalazine Generic | 35 | 101 | Under 11 | $1,800 |
| Azathioprine Generic | 34 | 100 | Under 11 | $1,796 |
| Pantoprazole Sodium Generic | 30 | 80 | 11 | $215 |
| Methotrexate Methotrexate Sodium | 28 | 47 | Under 11 | $606 |
| Prednisone Generic | 27 | 30 | 11 | $119 |
| Loperamide Loperamide Hcl | 25 | 34 | Under 11 | $1,409 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 25 | 27 | 11 | $840 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 25 | 25 | 25 | $343 |
| Mesalamine Er Mesalamine | 24 | 42 | Under 11 | $2,237 |
| Omeprazole Generic | 23 | 53 | 11 | $435 |
Brand drugs: 528 claims; generic drugs: 533 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Parakkal Deepak $122K ($122K in general payments such as food, travel and fees) from 17 companies. The largest payer was Janssen Biotech, Inc. with $55K.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 41 | $55K |
| Eli Lilly and Company LLY | 5 | $18K |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $14K |
| Sobi, Inc SOBI.ST | 10 | $12K |
| Merck Sharp & Dohme LLC MRK | 9 | $8,525 |
| Celltrion USA Inc. 068270.KS | 6 | $8,275 |
| Lilly USA, LLC LLY | 2 | $4,950 |
| Abbvie Inc. ABBV | 1 | $700 |
| Cordis US Corp. JNJ | 1 | $86.1 |
| Pfizer Inc. PFE | 1 | $73.17 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.